Sign in to view content

ZETA-1 Phase 2 Trial Efficacy Results for APX3330 a Novel Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy

David R Lally, MD

Video
Published 2023

Related

Relationships Between Total Retinal Volume and Visual and Anatomic Outcome Measures in Patients With Diabetic Macular Edema in RIDE and RISE
Michelle V. Carle, MD. MMEd
On Demand Cases, Courses, and Papers
2019
Venous Beading
Retina Image Bank: Images of the Week
2022
Intraoperative Fluorescein Angiography to Efficiently Identify Many Biomarkers and Guide Surgical Decision-Making
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more